Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - IN
$ 14.17
-0.492 %
$ 12.2 B
Market Cap
18.17
P/E
CASH FLOW STATEMENT
45.4 B
OPERATING CASH FLOW
-40.3 B
INVESTING CASH FLOW
-3.76 B
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Dr. Reddy's Laboratories Limited
| Net Income | 55.7 B |
| Depreciation & Amortization | 14.8 B |
| Capital Expenditures | -27.4 B |
| Stock-Based Compensation | 407 M |
| Change in Working Capital | -20.2 B |
| Others | -15.2 B |
| Free Cash Flow | 18 B |
Cash Flow
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 | Mar-2008 | Mar-2007 | Mar-2006 | Mar-2005 | Mar-2004 | Mar-2003 | Mar-2002 | Mar-2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||||||||
| Net Income | 55 684.0 | 60 485.0 | 23 568.0 | 19 149.0 | 19 498.0 | 18 795.0 | 9 806.0 | 12 039.0 | 20 013.0 | 22 179.0 | 21 512.0 | 16 776.0 | 14 262.0 | 11 040.0 | 1 068.0 | (5 168.0) | 4 678.0 | 9 348.9 | 1 633.1 | 211.3 | 2 479.5 | 3 522.2 | 4 915.6 | 739.3 |
| Depreciation & Amortization | 14 841.0 | 12 502.0 | 11 824.0 | 12 796.0 | 12 472.0 | 12 190.0 | 11 710.0 | 11 277.0 | 10 250.0 | 8 100.0 | 7 106.0 | 5 549.0 | 5 213.0 | 4 148.0 | 4 160.0 | 3 814.0 | 6 204.8 | 3 017.3 | 1 571.2 | 1 309.3 | 1 130.9 | 1 014.9 | 945.3 | 892.6 |
| Deferred Income Tax | 16 186.0 | 15 300.0 | 8 730.0 | 9 175.0 | (1 466.0) | 3 648.0 | 4 535.0 | 2 614.0 | 7 127.0 | 5 984.0 | 5 094.0 | 4 900.0 | 4 204.0 | 1 403.0 | 985.0 | 1 172.0 | (2 351.1) | (1 106.2) | (55.3) | (95.6) | (135.1) | 0.6 | (268.3) | 19.5 |
| Stock Based Compensation | 407.0 | 397.0 | 592.0 | 584.0 | 521.0 | 389.0 | 454.0 | 398.0 | 471.0 | 498.0 | 436.0 | 390.0 | 326.0 | 265.0 | 226.0 | 131.0 | 257.8 | 175.4 | 162.2 | 144.0 | 147 730.0 | 0 | 0 | 0 |
| Other Operating Activities | (21 503.0) | (21 956.0) | (2 692.0) | 2 287.0 | 6 352.0 | (547.0) | 488.0 | 535.0 | 3 574.0 | 3 312.0 | (4 296.0) | (1 152.0) | 1 105.0 | (2 109.0) | 8 334.0 | 12 823.0 | 592.6 | 3 456.7 | 214.4 | 609.4 | (147 365.8) | 494.3 | 352.8 | 46.6 K |
| Change in Working Capital | (20 182.0) | (7 855.0) | (13 914.0) | (8 288.0) | (7 536.0) | (5 771.0) | (8 964.0) | (5 350.0) | (188.0) | (15 040.0) | (10 389.0) | (13 146.0) | (8 960.0) | (6 738.0) | (1 547.0) | (8 267.0) | (3 259.5) | (3 059.6) | (1 878.1) | 113.2 | 168.5 | (677.8) | (1 297.7) | (1 287.3) |
| Cash From Operations | 45 433.0 | 58 873.0 | 28 108.0 | 35 703.0 | 29 841.0 | 28 704.0 | 18 029.0 | 21 513.0 | 41 247.0 | 25 033.0 | 19 463.0 | 13 317.0 | 16 150.0 | 8 009.0 | 13 226.0 | 4 505.0 | 6 122.6 | 11 832.5 | 1 647.4 | 2 291.6 | 4 007.9 | 4 354.2 | 4 647.7 | 614.9 |
| INVESTING CASH FLOW | ||||||||||||||||||||||||
| Capital Expenditures | (27 435.0) | (18 864.0) | (19 049.0) | (12 561.0) | (6 115.0) | (7 491.0) | (11 043.0) | (40 984.0) | (14 875.0) | (15 327.0) | (10 627.0) | (7 336.0) | (8 585.0) | (11 606.0) | (4 283.0) | (4 761.0) | (6 769.6) | (4 747.6) | (1 919.7) | (1 749.2) | (2 420.9) | (1 511.4) | (1 089.1) | (487.2) |
| Other Items | (12 848.0) | (22 507.0) | (7 338.0) | (10 099.0) | 1 192.0 | (236.0) | (3 840.0) | 22 513.0 | (5 548.0) | (7 577.0) | (5 993.0) | (6 608.0) | (10 080.0) | 2 948.0 | (2 715.0) | 1 289.0 | (2 830.4) | 5 341.5 | (32 693.9) | 2 382.1 | (4 099.3) | (437.7) | (442.1) | (199.7) |
| Cash From Investing Activities | (40 283.0) | (41 371.0) | (26 387.0) | (22 660.0) | (4 923.0) | (7 727.0) | (14 883.0) | (18 471.0) | (20 423.0) | (22 904.0) | (16 620.0) | (13 944.0) | (18 665.0) | (8 658.0) | (6 998.0) | (3 472.0) | (9 600.0) | 593.9 | (34 613.7) | 632.9 | (6 520.2) | (1 949.1) | (1 531.2) | (686.9) |
| FINANCING CASH FLOW | ||||||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | (1 193.0) | (474.0) | (535.0) | 0 | (15 694.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (116.2) | 0 | 0 | 0 |
| Total Debt Repaid | (1 147.0) | (1 015.0) | 2 735.0 | (697.0) | (19 165.0) | (15 182.0) | 882.0 | (5 220.0) | (11 979.0) | (3 716.0) | 3 957.0 | 2 293.0 | 7 054.0 | 8 677.0 | (3 562.0) | (1 794.0) | (7 143.0) | (7 777.7) | 27 986.1 | 2 362.9 | 166.3 | 38.2 | (3 795.1) | 46.7 |
| Dividends Paid | (6 648.0) | (4 979.0) | (4 146.0) | (4 147.0) | (3 916.0) | (4 002.0) | (3 992.0) | (3 390.0) | (4 106.0) | (3 067.0) | (2 985.0) | (2 714.0) | (2 216.0) | (3 063.0) | (1 233.0) | (738.0) | (737.3) | (438.5) | (437.5) | (431.6) | (432.5) | (190.8) | (561.0) | (134.0) |
| Other Financing Activities | 3 227.0 | (21 235.0) | (1 345.0) | 5 470.0 | (2 210.0) | (1 607.0) | (1 331.0) | 20 611.0 | (1 612.0) | 3 185.0 | (1 191.0) | (1 372.0) | (1 109.0) | (6 020.0) | (529.0) | 0 | 0.3 | (79.2) | (341.1) | 0.08 | 43.4 K | (152 868.4) | 48.7 K | 0.84 |
| Cash From Financing Activities | (3 763.0) | (26 861.0) | (2 422.0) | (298.0) | (25 159.0) | (21 326.0) | (4 440.0) | (3 692.0) | (17 001.0) | (4 118.0) | (217.0) | (1 792.0) | 3 735.0 | (377.0) | (5 307.0) | (2 527.0) | (6 827.6) | 1 757.9 | 27 281.3 | 1 931.3 | (376.9) | (152.6) | 1 420.2 | (87.3) |
| CHANGE IN CASH | ||||||||||||||||||||||||
| Net Change In Cash | 1 328.0 | (9 073.0) | 32.0 | 12 858.0 | (266.0) | (314.0) | (1 237.0) | (1 142.0) | (473.0) | (3 057.0) | 3 397.0 | (2 325.0) | 1 719.0 | (885.0) | 1 167.0 | (1 608.0) | (10 583.2) | 14 302.6 | (5 589.7) | 4 911.6 | (2 903.4) | 2 157.8 | 4 625.3 | (78.3) |
| FREE CASH FLOW | ||||||||||||||||||||||||
| Free Cash Flow | 17 998.0 | 40 009.0 | 9 059.0 | 23 142.0 | 23 726.0 | 21 213.0 | 6 986.0 | (19 471.0) | 26 372.0 | 9 706.0 | 8 836.0 | 5 981.0 | 7 565.0 | (3 597.0) | 8 943.0 | (256.0) | (647.0) | 7 084.9 | (272.3) | 542.4 | 1 587.0 | 2 842.8 | 3 558.5 | 127.7 |